Changes in urinary monoamine excretion in hyperkinetic children

Related Experiment Video

Updated: Sep 20, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

Marat G Uzbekov1, Eduard Y Misionzhnik

  • 1Department of Brain Pathology, Research Institute of Psychiatry, Poteshnaya 3, Moscow, Russia. uzbekovmg@mtu-net.ru

Human Psychopharmacology
|August 19, 2003
PubMed

Insights

Children with severe hyperkinetic syndrome (HKS) show significantly higher L-dopa, dopamine, and adrenaline excretion than those with mild HKS. These findings highlight distinct monoamine metabolism differences crucial for targeted HKS treatment.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Biochemistry

Background:

  • Hyperkinetic syndrome (HKS) pathogenesis remains unclear, necessitating further research.
  • Understanding monoamine metabolism variations in HKS is crucial for effective treatment strategies.

Purpose of the Study:

  • To identify specific monoamine metabolism features differentiating mild and severe hyperkinetic syndrome in children.
  • To investigate urinary excretion levels of key monoamine metabolites in pediatric HKS.

Main Methods:

  • Collected and analyzed 24-hour urine samples from children aged 7-11 years diagnosed with mild or severe HKS.
  • Quantified levels of L-dopa, dopamine, noradrenaline, adrenaline, homovanillic acid, vanillylmandelic acid, and 5-hydroxyindoleacetic acid.
  • Employed fluorimetric and chromatographic techniques for precise metabolite measurements.

Main Results:

  • Severe HKS exhibited significantly elevated urinary excretion of L-dopa (186% increase), dopamine (201% increase), and adrenaline (160% increase) compared to mild HKS.
  • Urinary noradrenaline levels remained comparable between mild and severe HKS groups.
  • Demonstrated distinct patterns in monoamine metabolism between the two severity levels of HKS.

Conclusions:

  • Significant differences in monoamine metabolism exist between mild and severe forms of hyperkinetic syndrome in children.
  • These metabolic distinctions may inform the development of tailored pharmacotherapeutic approaches for varying degrees of HKS severity.

More Related Videos

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a drug,...